Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer
Clinical trial NCT05975749 · RECRUITING
Trial details
- NCT number
- NCT05975749
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.